Events Stine Krag Brunvold 11/30/24 Events Stine Krag Brunvold 11/30/24 ClC-1 inhibition for improvement of muscle function in CMT webinar Read More Events Stine Krag Brunvold 4/25/24 Events Stine Krag Brunvold 4/25/24 Watch Cure SMA's Clinical Trial Update Webinar with NMD Pharma Read More Events Stine Krag Brunvold 3/21/24 Events Stine Krag Brunvold 3/21/24 NMD Pharma Publishes Comprehensive Data Package for NMD670 in Science Translational Medicine Read More Events Stine Krag Brunvold 2/28/23 Events Stine Krag Brunvold 2/28/23 Rare Disease Day, 28 February 2023 Read More Events Stine Krag Brunvold 10/11/22 Events Stine Krag Brunvold 10/11/22 Today we are able to announce positive topline data from our Phase I/IIa clinical trial of NMD670 in patients with Myasthenia Gravis Read More Events Stine Krag Brunvold 8/16/22 Events Stine Krag Brunvold 8/16/22 NMD Pharma at ICFSR 2022 - Symposium 4 - Part 1 Read More Events Stine Krag Brunvold 8/16/22 Events Stine Krag Brunvold 8/16/22 NMD Pharma at ICFSR 2022 - Symposium 4 - Part 2 Read More Events Stine Krag Brunvold 8/16/22 Events Stine Krag Brunvold 8/16/22 NMD Pharma at ICFSR 2022 - Symposium 4 - Part 3 Read More Events Stine Krag Brunvold 8/16/22 Events Stine Krag Brunvold 8/16/22 NMD Pharma at ICFSR 2022 - Symposium 4 - Part 4 - Q&A Read More Events Stine Krag Brunvold 7/7/22 Events Stine Krag Brunvold 7/7/22 An active future made possible by the power of science Read More
Events Stine Krag Brunvold 11/30/24 Events Stine Krag Brunvold 11/30/24 ClC-1 inhibition for improvement of muscle function in CMT webinar Read More
Events Stine Krag Brunvold 4/25/24 Events Stine Krag Brunvold 4/25/24 Watch Cure SMA's Clinical Trial Update Webinar with NMD Pharma Read More
Events Stine Krag Brunvold 3/21/24 Events Stine Krag Brunvold 3/21/24 NMD Pharma Publishes Comprehensive Data Package for NMD670 in Science Translational Medicine Read More
Events Stine Krag Brunvold 2/28/23 Events Stine Krag Brunvold 2/28/23 Rare Disease Day, 28 February 2023 Read More
Events Stine Krag Brunvold 10/11/22 Events Stine Krag Brunvold 10/11/22 Today we are able to announce positive topline data from our Phase I/IIa clinical trial of NMD670 in patients with Myasthenia Gravis Read More
Events Stine Krag Brunvold 8/16/22 Events Stine Krag Brunvold 8/16/22 NMD Pharma at ICFSR 2022 - Symposium 4 - Part 1 Read More
Events Stine Krag Brunvold 8/16/22 Events Stine Krag Brunvold 8/16/22 NMD Pharma at ICFSR 2022 - Symposium 4 - Part 2 Read More
Events Stine Krag Brunvold 8/16/22 Events Stine Krag Brunvold 8/16/22 NMD Pharma at ICFSR 2022 - Symposium 4 - Part 3 Read More
Events Stine Krag Brunvold 8/16/22 Events Stine Krag Brunvold 8/16/22 NMD Pharma at ICFSR 2022 - Symposium 4 - Part 4 - Q&A Read More
Events Stine Krag Brunvold 7/7/22 Events Stine Krag Brunvold 7/7/22 An active future made possible by the power of science Read More
